FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1999062502> ?p ?o ?g. }

• W1999062502 endingPage "12" @default.
• W1999062502 startingPage "4" @default.
• W1999062502 abstract "Thalidomide has immunomodulatory and anti-angiogenic properties which may underlie its activity in cancer. After its success in myeloma, it has been investigated in other plasma cell dyscrasias, myelodysplastic syndromes, gliomas, Kaposi’s sarcoma, renal cell carcinoma, advanced breast cancer, and colon cancer. Thalidomide causes responses in 30–50% of myeloma patients as a single agent, and acts synergistically with corticosteroids and chemotherapy. Thalidomide results in the reduction or elimination of transfusion-dependence in some patients with myelodysplastic syndrome. Responses have also been seen in one-third of patients with Kaposi’s sarcoma, in a small proportion of patients with renal cell carcinoma and high-grade glioma, and in some patients with colon cancer in combination with irinotecan. The drug is being investigated currently in a number of clinical trials for cancer. Drowsiness, constipation, and fatigue are common side effects, whereas peripheral neuropathy and skin rash are seen in one-third. A minority of patients experience bradycardia. Thrombotic phenomena are especially common when thalidomide is combined with chemotherapy. Adverse effects severe enough to necessitate cessation of therapy are seen in around 20% of patients. A therapeutic trial of thalidomide is essential in all patients with relapsed or refractory myeloma. In other cancers, the best way to use the drug is in the setting of clinical trials. In the absence of access to studies or alternative therapeutic options, thalidomide could be considered singly or in combination with standard therapy." @default.
• W1999062502 created "2016-06-24" @default.
• W1999062502 creator A5040773022 @default.
• W1999062502 creator A5084178169 @default.
• W1999062502 date "2002-02-01" @default.
• W1999062502 modified "2023-10-18" @default.
• W1999062502 title "Thalidomide in cancer" @default.
• W1999062502 cites W1799516048 @default.
• W1999062502 cites W1885167687 @default.
• W1999062502 cites W1912068049 @default.
• W1999062502 cites W1924027236 @default.
• W1999062502 cites W1938023575 @default.
• W1999062502 cites W1940514332 @default.
• W1999062502 cites W1946820747 @default.
• W1999062502 cites W1947748380 @default.
• W1999062502 cites W1965988259 @default.
• W1999062502 cites W1970583650 @default.
• W1999062502 cites W1978557775 @default.
• W1999062502 cites W1981813235 @default.
• W1999062502 cites W1982060996 @default.
• W1999062502 cites W1983391533 @default.
• W1999062502 cites W1985147506 @default.
• W1999062502 cites W1985658104 @default.
• W1999062502 cites W1986130129 @default.
• W1999062502 cites W1988605844 @default.
• W1999062502 cites W1993572786 @default.
• W1999062502 cites W1997680923 @default.
• W1999062502 cites W2000155764 @default.
• W1999062502 cites W2000969879 @default.
• W1999062502 cites W2010235547 @default.
• W1999062502 cites W2015111816 @default.
• W1999062502 cites W2024708384 @default.
• W1999062502 cites W2028705933 @default.
• W1999062502 cites W2034031119 @default.
• W1999062502 cites W2040111432 @default.
• W1999062502 cites W2042774683 @default.
• W1999062502 cites W2044418674 @default.
• W1999062502 cites W2047043504 @default.
• W1999062502 cites W2056291926 @default.
• W1999062502 cites W2067754607 @default.
• W1999062502 cites W2077942597 @default.
• W1999062502 cites W2080024052 @default.
• W1999062502 cites W2081446774 @default.
• W1999062502 cites W2087775691 @default.
• W1999062502 cites W2093916615 @default.
• W1999062502 cites W2117327010 @default.
• W1999062502 cites W2119810076 @default.
• W1999062502 cites W2125559109 @default.
• W1999062502 cites W2132242107 @default.
• W1999062502 cites W2133986577 @default.
• W1999062502 cites W2136226957 @default.
• W1999062502 cites W2159746652 @default.
• W1999062502 cites W2162559503 @default.
• W1999062502 cites W2168663436 @default.
• W1999062502 cites W2316160054 @default.
• W1999062502 cites W2338946788 @default.
• W1999062502 cites W2417793136 @default.
• W1999062502 cites W4251021052 @default.
• W1999062502 cites W4251797779 @default.
• W1999062502 doi "https://doi.org/10.1016/s0753-3322(01)00146-9" @default.
• W1999062502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11905508" @default.
• W1999062502 hasPublicationYear "2002" @default.
• W1999062502 type Work @default.
• W1999062502 sameAs 1999062502 @default.
• W1999062502 citedByCount "114" @default.
• W1999062502 countsByYear W19990625022012 @default.
• W1999062502 countsByYear W19990625022013 @default.
• W1999062502 countsByYear W19990625022014 @default.
• W1999062502 countsByYear W19990625022015 @default.
• W1999062502 countsByYear W19990625022016 @default.
• W1999062502 countsByYear W19990625022017 @default.
• W1999062502 countsByYear W19990625022018 @default.
• W1999062502 countsByYear W19990625022019 @default.
• W1999062502 countsByYear W19990625022020 @default.
• W1999062502 countsByYear W19990625022021 @default.
• W1999062502 countsByYear W19990625022022 @default.
• W1999062502 countsByYear W19990625022023 @default.
• W1999062502 crossrefType "journal-article" @default.
• W1999062502 hasAuthorship W1999062502A5040773022 @default.
• W1999062502 hasAuthorship W1999062502A5084178169 @default.
• W1999062502 hasConcept C121608353 @default.
• W1999062502 hasConcept C126322002 @default.
• W1999062502 hasConcept C143998085 @default.
• W1999062502 hasConcept C2776364478 @default.
• W1999062502 hasConcept C2776694085 @default.
• W1999062502 hasConcept C2778524551 @default.
• W1999062502 hasConcept C2779609412 @default.
• W1999062502 hasConcept C71924100 @default.
• W1999062502 hasConcept C90924648 @default.
• W1999062502 hasConceptScore W1999062502C121608353 @default.
• W1999062502 hasConceptScore W1999062502C126322002 @default.
• W1999062502 hasConceptScore W1999062502C143998085 @default.
• W1999062502 hasConceptScore W1999062502C2776364478 @default.
• W1999062502 hasConceptScore W1999062502C2776694085 @default.
• W1999062502 hasConceptScore W1999062502C2778524551 @default.
• W1999062502 hasConceptScore W1999062502C2779609412 @default.
• W1999062502 hasConceptScore W1999062502C71924100 @default.
• W1999062502 hasConceptScore W1999062502C90924648 @default.

• next